AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease

RecruitingNAAges 40 Years - anyAllPusan National University Yangsan Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Individuals diagnosed with Parkinson's disease at Hoehn and Yahr stages 1-3 based on medical history and examination * Adults aged 40 years or older * Individuals able to walk independently Exclusion Criteria: * Individuals with severe cognitive impairment (Korean Mini-Mental State Examination \[K-MMSE\] score โ‰ค 9) making it difficult to understand and perform tasks * Patients with dementia other than Parkinson's disease dementia * Individuals with implanted medical or other electronic devices * Individuals with severe neuropsychiatric disorders * Individuals treated for alcohol dependence within 6 months prior to screening * Individuals with a history of suicide attempts * Individuals with a history of seizures * Individuals experiencing dyspnea while sitting at rest * Individuals with visual impairment preventing them from reading ordinary text even with corrective lenses * Individuals with hearing impairment preventing them from understanding conversation even with a hearing aid * Individuals who have participated in two or more clinical trials in the same year or in another clinical trial within the past 6 months * Women and men of childbearing potential who are planning pregnancy during the trial or who do not agree to use appropriate contraceptive methods * Pregnant or breastfeeding women * Individuals deemed medically inappropriate for participation by the principal investigator or study staff based on clinically significant findings not otherwise specified above
๐Ÿ’Š

What it tests

  • Photobiomodulation
๐Ÿ“

Where

1 site
Pusan National University Yangsan Hospital
Yangsan, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy